Cargando…
Dengue Therapeutics, Chemoprophylaxis, and Allied Tools: State of the Art and Future Directions
Dengue is the most common arboviral disease of humans. There is an unmet need for a therapeutic intervention that reduces the duration and severity of dengue symptoms and diminishes the likelihood of severe complications. To this end, there are active discovery efforts in industry and academia to de...
Autores principales: | Whitehorn, James, Yacoub, Sophie, Anders, Katherine L., Macareo, Louis R., Cassetti, M. Cristina, Nguyen Van, Vinh Chau, Shi, Pei-Yong, Wills, Bridget, Simmons, Cameron P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4148227/ https://www.ncbi.nlm.nih.gov/pubmed/25166493 http://dx.doi.org/10.1371/journal.pntd.0003025 |
Ejemplares similares
-
Dengue Human Infection Models Supporting Drug Development
por: Whitehorn, James, et al.
Publicado: (2014) -
Therapeutics for Dengue: Recommendations for Design and Conduct of Early-Phase Clinical Trials
por: Simmons, Cameron P., et al.
Publicado: (2012) -
Predicting outcome from dengue
por: Yacoub, Sophie, et al.
Publicado: (2014) -
Genetic variants of MICB and PLCE1 and associations with the laboratory features of dengue
por: Whitehorn, James, et al.
Publicado: (2017) -
Epidemiological Factors Associated with Dengue Shock Syndrome and Mortality in Hospitalized Dengue Patients in Ho Chi Minh City, Vietnam
por: Anders, Katherine L., et al.
Publicado: (2011)